709: John Abramson | How Big Pharma Broke American Health Care

Pricing Issues

The pharmaceutical industry's pricing strategies have led to inflated costs for patients and the healthcare system. John Abramson highlights the case of Vioxx, a drug that caused 40,000 to 60,000 deaths, yet resulted in no significant financial loss for its manufacturer, Merck 1. This reflects a broader issue where companies prioritize profits over patient safety. Additionally, insulin analogs are marketed at exorbitant prices despite no evidence of superiority over cheaper alternatives 2. Abramson notes, "We spend gazillions of dollars prescribing drugs that have nowhere near the benefit that Vioxx caused harm."

We spend gazillions of dollars prescribing drugs that have nowhere near the benefit that Vioxx caused harm.

--- John Abramson

This pricing strategy is driven by marketing rather than medical efficacy, distorting the market and leading to less effective treatments.

   

Regulatory Failures

Regulatory failures in the US allow unethical pharmaceutical practices to persist, with companies exploiting the system for profit. John Abramson explains that the lack of proper regulation enables companies to maintain high prices, as seen with insulin analogs, where a $35 copay plan benefits manufacturers more than consumers 3. This protectionism contradicts the principles of capitalism, as companies avoid fair competition. Abramson states, "The job of a corporation, at least in the United States, is to maximize its profits. The problem is that we don't have guardrails."

The job of a corporation, at least in the United States, is to maximize its profits. The problem is that we don't have guardrails.

--- John Abramson

Furthermore, vaccine profits highlight how government inaction allows pharmaceutical companies to prioritize financial gain over public health 4.